# VanEck Pharmaceutical ETF (PPH)

> Source: Nexqual · https://nexqual.com/PPH · data as of 2026-10-23 20:00 UTC · cite as "Nexqual, VanEck Pharmaceutical ETF (PPH), nexqual.com/PPH" · informational, not investment advice.

**Price:** USD 114.93 (-1.78% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 117.01 · day 114.53–116.68 · 52w 90.74–118.03 · market cap null · NGM

## Key facts
- Total return with dividends: 1Y +26.9% vs S&P 500 +13.4%; 5Y +68.5% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +26.9% | +68.5% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +27.0% | +11.0% |
| Volatility (annualized) | 18.4% | 16.4% |
| Max drawdown | -10.8% (Feb 2026→Apr 2026) | -19.6% (Apr 2022→Sep 2022) |

## Peers
BBH (VanEck Biotech ETF) USD 246.57 -0.74% · HHH (Howard Hughes Holdings Inc.) USD 70.19 +1.01% · RTH (VanEck Retail ETF) USD 267.89 -1.72% · IYH (iShares U.S. Healthcare ETF) USD 75.4 -1.08% · IHE (iShares U.S. Pharmaceutical ETF) USD 102.51 -2.17%

## More
Full page: https://nexqual.com/PPH · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt